News

Asia One7y
MicroPort(TM)'s Firehawk(TM) Drug Eluting Stent Achieves Primary Endpoint and Shows Very Promising Results From TARGET All-Comers Clinical Trial
The results of the TARGET AC trial demonstrated that vessels treated with the Firehawk sirolimus ... Clinical Science & Medical Affairs, for MicroPort™. "The remarkably low rates of target ...
Stockhouse6y
Firehawk® Clinical Data From The TARGET AC European Clinical Trial Has Been Accepted For Publication In The Prestigious Medical Journal The Lancet
We strongly believe and expect that the Firehawk® stent will be used to save millions of patients globally in the years to come. As a company, MicroPort® will continue to be at the forefront of ...
health.economictimes.indiatimes8y
MicroPort enters Indian market with Firehawk (Target Eluting Stent)
The Indian arm MicroPort Scientific India Pvt. Ltd., a wholly owned subsidiary of MPSC, is aimed to serve the Indian patients with high-quality and yet affordable medical solutions to save ...
Medindia7y
MicroPort(TM)'s Firehawk(TM) Drug Eluting Stent Achieves Primary Endpoint and Shows Very Promising Results From TARGET All-Comers Clinical Trial
"With this European clinical data set, Firehawk™ has the potential ... Clinical Science & Medical Affairs, for MicroPort™. "The remarkably low rates of target lesion revascularization at ...
Asia One6y
Firehawk Clinical Data From The TARGET AC European Clinical Trial Has Been Accepted For Publication In The Prestigious Medical Journal The Lancet
4, 2018 /PRNewswire/ -- MicroPort ... ("Firehawk®") which conducted a multi-center, randomized controlled trial called TARGET AC has been published online in The Lancet, a world leading medical ...